Abstract:POSTN+ CAFs were enriched in advanced NSCLC tumours and presented gene expression signatures related to extracellular matrix remodeling, tumour invasion and immune suppression. POSTN+ CAFs were in close localization with SPP1+ macrophages and associated with the exhausted phenotype and lower infiltration of T cells. POSTN expression and POSTN+ CAFs were prognostic factors for NSCLC. Background Cancer‐associated fibroblasts (CAFs) are potential targets for cancer therapy. Due to the heterogeneity of CAFs, the influence of CAF subpopulations on the progression of lung cancer is still unclear, which impedes the translational advances in targeting CAFs. Methods We performed single‐cell RNA sequencing (scRNA‐seq) on tumour, paired tumour‐adjacent, and normal samples from 16 non‐small cell lung cancer (NSCLC) patients. CAF subpopulations were analyzed after integration with published NSCLC scRNA‐seq data. SpaTial enhanced resolution omics‐sequencing (Stereo‐seq) was applied in tumour and tumour‐adjacent samples from seven NSCLC patients to map the architecture of major cell populations in tumour microenvironment (TME). Immunohistochemistry (IHC) and multiplexed IHC (mIHC) were used to validate marker gene expression and the association of CAFs with immune infiltration in TME. Results A subcluster of myofibroblastic CAFs, POSTN+ CAFs, were significantly enriched in advanced tumours and presented gene expression signatures related to extracellular matrix remodeling, tumour invasion pathways and immune suppression. Stereo‐seq and mIHC demonstrated that POSTN+ CAFs were in close localization with SPP1+ macrophages and were associated with the exhausted phenotype and lower infiltration of T cells. POSTN expression or the abundance of POSTN+ CAFs were associated with poor prognosis of NSCLC. Conclusions Our study identified a myofibroblastic CAF subpopulation, POSTN+ CAFs, which might associate with SPP1+ macrophages to promote the formation of desmoplastic architecture and participate in immune suppression. Furthermore, we showed that POSTN+ CAFs associated with cancer progression and poor clinical outcomes and may provide new insights on the treatment of NSCLC.

CNOT4 suppresses nonsmall cell lung cancer progression by promoting the degradation of PAF1

CNOT4 suppresses non-small cell lung cancer progression and is required for effector cytolytic T lymphocytes cell responses to lung cancer cells

CNOT4 enhances the efficacy of anti-PD-1 immunotherapy in a model of non-small cell lung cancer

ATF4/NUPR1 Axis Promotes Cancer Cell Survival and Mediates Immunosuppression in Clear Cell Renal Cell Carcinoma

AOC4P Suppresses Viability and Invasion and Induces Apoptosis in NSCLC Cells by Inhibiting the Wnt/β-catenin Pathway.

CNOT3 targets negative cell cycle regulators in non-small cell lung cancer development

circPTP4A2 knockdown suppresses NSCLC progression via regulating proliferation and activating anti-tumor immunity

An RFC4/Notch1 signaling feedback loop promotes NSCLC metastasis and stemness

NOX4 promotes non-small cell lung cancer cell proliferation and metastasis through positive feedback regulation of PI3K/Akt signaling.

circRNA-CPA4 Regulates Cell Proliferation and Apoptosis of Non-small Cell Lung Cancer via the miR-1183/PDPK1 Axis

CPSF4 promotes tumor-initiating phenotype by enhancing VEGF/NRP2/TAZ signaling in lung cancer

ATF4 inhibits tumor development and mediates p-GCN2/ASNS upregulation in colon cancer

Overexpression of Krüppel-Like Factor 4 Suppresses Migration and Invasion of Non-Small Cell Lung Cancer Through C-Jun-nh2-terminal Kinase/Epithelial-Mesenchymal Transition Signaling Pathway

CNOT1 cooperates with LMNA to aggravate osteosarcoma tumorigenesis through the Hedgehog signaling pathway

4.1N is Involved in a Flotillin-1/Β-catenin/wnt Pathway and Suppresses Cell Proliferation and Migration in Non-Small Cell Lung Cancer Cell Lines

Inhibition of PC4 Radiosensitizes Non‐small Cell Lung Cancer by Transcriptionally Suppressing XLF

IKZF4 acts as a novel tumor suppressor in non–small cell lung cancer by suppressing Notch signaling pathway

Interferon Regulatory Factor 4 (IRF4) is Overexpressed in Human Non-Small Cell Lung Cancer (NSCLC) and Activates the Notch Signaling Pathway

LncRNA FOXP4-AS promotes the progression of non-small cell lung cancer by regulating the miR-3184-5p/EIF5A axis

Circular RNA circ-CPA4/ let-7 miRNA/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC)

Single‐cell and spatial transcriptomics reveal POSTN+ cancer‐associated fibroblasts correlated with immune suppression and tumour progression in non‐small cell lung cancer